<status value="active"/> <publisher value="Computable Publishing LLC"/> <contact> <telecom> <system value="email"/> <value value="support@computablepublishing.com"/> </telecom> </contact> <description value="Inclusion Criteria: * Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia * Adult (18 Years and above) * Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative). * Understands and agrees to comply with planned study procedures. * Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH. Exclusion Criteria: * Patients with pneumonia or severe illness requiring admission to ICU. * Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \< 30) or end stage renal disease requiring dialysis * Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \> 5 times the upper limit of normal). * Pregnancy or breast feeding. * Anticipated transfer to another hospital which is not a study site within 72 hours. * Allergy to any study medication."/> <copyright value="Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse)."/> <membership value="conceptual"/> <combinationMethod value="all-of"/> <characteristic> <code> <text value="Defined by CodeableConcept"/> </code> <valueCodeableConcept> <text value="Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia"/> </valueCodeableConcept> <exclude value="false"/> <description value="Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia"/> </characteristic> <characteristic> <code> <text value="Defined by CodeableConcept"/> </code> <valueCodeableConcept> <text value="Adult (18 Years and above)"/> </valueCodeableConcept> <exclude value="false"/> <description value="Adult (18 Years and above)"/> </characteristic> <characteristic> <code> <text value="Defined by CodeableConcept"/> </code> <valueCodeableConcept> <text value="Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative)."/> </valueCodeableConcept> <exclude value="false"/> <description value="Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative)."/> </characteristic> <characteristic> <code> <text value="Defined by CodeableConcept"/> </code> <valueCodeableConcept> <text value="Understands and agrees to comply with planned study procedures."/> </valueCodeableConcept> <exclude value="false"/> <description value="Understands and agrees to comply with planned study procedures."/> </characteristic> <characteristic> <code> <text value="Defined by CodeableConcept"/> </code> <valueCodeableConcept> <text value="Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH."/> </valueCodeableConcept> <exclude value="false"/> <description value="Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH."/> </characteristic> <characteristic> <code> <text value="Defined by CodeableConcept"/> </code> <valueCodeableConcept> <text value="Patients with pneumonia or severe illness requiring admission to ICU."/> </valueCodeableConcept> <exclude value="true"/> <description value="Patients with pneumonia or severe illness requiring admission to ICU."/> </characteristic> <characteristic> <code> <text value="Defined by CodeableConcept"/> </code> <valueCodeableConcept> <text value="Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \< 30) or end stage renal disease requiring dialysis"/> </valueCodeableConcept> <exclude value="true"/> <description value="Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \< 30) or end stage renal disease requiring dialysis"/> </characteristic> <characteristic> <code> <text value="Defined by CodeableConcept"/> </code> <valueCodeableConcept> <text value="Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \> 5 times the upper limit of normal)."/> </valueCodeableConcept> <exclude value="true"/> <description value="Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \> 5 times the upper limit of normal)."/> </characteristic> <characteristic> <code> <text value="Defined by CodeableConcept"/> </code> <valueCodeableConcept> <text value="Pregnancy or breast feeding."/> </valueCodeableConcept> <exclude value="true"/> <description value="Pregnancy or breast feeding."/> </characteristic> <characteristic> <code> <text value="Defined by CodeableConcept"/> </code> <valueCodeableConcept> <text value="Anticipated transfer to another hospital which is not a study site within 72 hours."/> </valueCodeableConcept> <exclude value="true"/> <description value="Anticipated transfer to another hospital which is not a study site within 72 hours."/> </characteristic> <characteristic> <code> <text value="Defined by CodeableConcept"/> </code> <valueCodeableConcept> <text value="Allergy to any study medication."/> </valueCodeableConcept> <exclude value="true"/> <description value="Allergy to any study medication."/> </characteristic> </Group>

Generated Narrative: Group 189713

version: 3; Last updated: 2026-08-05 07:33:36+0000

ArtifactPublicationStatus: Active

Artifact Author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:

CiteAs:

NCT04401202 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 189713. Revised 2026-08-05. Available at: https://fevir.net/resources/Group/189713. Computable resource at: https://fevir.net/resources/Group/189713#json.

url: https://fevir.net/resources/Group/189713

identifier: FEvIR Object Identifier/189713, FEvIR Linking Identifier/NCT04401202 Eligibility Criteria

name: NCT04401202_Eligibility_Criteria

title: NCT04401202 Eligibility Criteria

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

Inclusion Criteria:

Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia
Adult (18 Years and above)
Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).
Understands and agrees to comply with planned study procedures.
Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH. Exclusion Criteria:
Patients with pneumonia or severe illness requiring admission to ICU.
Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) < 30) or end stage renal disease requiring dialysis
Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) > 5 times the upper limit of normal).
Pregnancy or breast feeding.
Anticipated transfer to another hospital which is not a study site within 72 hours.
Allergy to any study medication.

copyright:

Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).

membership: Conceptual

combinationMethod: All of

characteristic
code: Defined by CodeableConcept
value: Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia
exclude: false
description:
Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia

characteristic
code: Defined by CodeableConcept
value: Adult (18 Years and above)
exclude: false
description:
Adult (18 Years and above)

characteristic
code: Defined by CodeableConcept
value: Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).
exclude: false
description:
Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).

characteristic
code: Defined by CodeableConcept
value: Understands and agrees to comply with planned study procedures.
exclude: false
description:
Understands and agrees to comply with planned study procedures.

characteristic
code: Defined by CodeableConcept
value: Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.
exclude: false
description:
Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.

characteristic
code: Defined by CodeableConcept
value: Patients with pneumonia or severe illness requiring admission to ICU.
exclude: true
description:
Patients with pneumonia or severe illness requiring admission to ICU.

characteristic
code: Defined by CodeableConcept
value: Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \< 30) or end stage renal disease requiring dialysis
exclude: true
description:
Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) < 30) or end stage renal disease requiring dialysis

characteristic
code: Defined by CodeableConcept
value: Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \> 5 times the upper limit of normal).
exclude: true
description:
Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) > 5 times the upper limit of normal).

characteristic
code: Defined by CodeableConcept
value: Pregnancy or breast feeding.
exclude: true
description:
Pregnancy or breast feeding.

characteristic
code: Defined by CodeableConcept
value: Anticipated transfer to another hospital which is not a study site within 72 hours.
exclude: true
description:
Anticipated transfer to another hospital which is not a study site within 72 hours.

characteristic
code: Defined by CodeableConcept
value: Allergy to any study medication.
exclude: true
description:
Allergy to any study medication.